CPA
CYRX icon

Capital Performance Advisors’s CryoPort CYRX Stock Holding History

Capital Performance Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-58
Closed -$470 – 798
2024
Q3 		$470 Buy
+58
New +$475 ﹤0.01% 2283

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
TAM
Thematics Asset Management Paris, France $2.2B AUM 18.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Capital Performance Advisors's CYRX Position: Q4 2024 in Review

Capital Performance Advisors sold out of CryoPort (CYRX) in Q4 2024, closing a stake of 58 shares — an estimated $470 sold.

Capital Performance Advisors first reported a position in CYRX in Q3 2024 and held it in 1 quarter. The position peaked at $470 in Q3 2024. 161 funds tracked by Wall St. Rank hold CYRX as of Q4 2024.

  • Capital Performance Advisors reported no remaining CryoPort position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 58 CryoPort shares in Q4 2024, an estimated $470.
  • Capital Performance Advisors first reported a position in CryoPort in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's CryoPort position peaked at $470 in Q3 2024.
  • 161 funds tracked by Wall St. Rank held CryoPort as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.